John Hussman's BMRN Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 31,500 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $1.87 M, representing 0.45% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in BMRN, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 10,500 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +10,500 | Add 50.00% | 31,500 | $59.43 |
| Q3 2025 | +21,000 | New Buy | 21,000 | $54.16 |
John Hussman's BioMarin Pharmaceutical Investment FAQs
John Hussman first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q3 2025, acquiring 21,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held BioMarin Pharmaceutical Inc. (BMRN) for 2 quarters since Q3 2025.
John Hussman's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q3 2025, adding 21,000 shares worth $1.14 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 31,500 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $1.87 M.
As of the Q4 2025 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.45% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 31,500 shares, as reported at the end of Q4 2025.